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Abstract
Objectives The management of incidentally detected
gallbladder polyps on radiological examinations is con-
tentious. The incidental radiological finding of a gall-
bladder polyp can therefore be problematic for the radi-
ologist and the clinician who referred the patient for the
radiological examination. To address this a joint guide-
l ine was created by the European Socie ty of
Gastrointestinal and Abdominal Radiology (ESGAR),
European Association for Endoscopic Surgery and other
Interventional Techniques (EAES), International Society
of Digestive Surgery – European Federation (EFISDS)
and European Society of Gastrointestinal Endoscopy
(ESGE).
Methods A targeted literature search was performed and con-
sensus guidelines were created using a series of Delphi ques-
tionnaires and a seven-point Likert scale.
Results A total of three Delphi rounds were performed.
Consensus regarding which patients should have cholecystec-
tomy, which patients should have ultrasound follow-up and the
nature and duration of that follow-up was established. The full
recommendations as well as a summary algorithm are provided.
Conclusions These expert consensus recommendations can
be used as guidance when a gallbladder polyp is encountered
in clinical practice.
Key Points
• Management of gallbladder polyps is contentious
• Cholecystectomy is recommended for gallbladder polyps
>10 mm
• Management of polyps <10 mm depends on patient and
polyp characteristics
• Further research is required to determine optimal manage-
ment of gallbladder polyps
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Abbreviations
ADC apparent diffusion coefficient
AGREE Appraisal of Guidelines for Research &
Evaluation
CEUS contrast enhanced ultrasound
CT computed tomography
DWI diffusion weighted imaging
ESGAR European Society of Gastrointestinal and
Abdominal Radiology
EUS endoscopic ultrasound
GRADE Grading of Recommendations Assessment
Development and Evaluation
HRUS high resolution ultrasound
MDT multidisciplinary team
PSC primary sclerosing cholangitis
Introduction
Gallbladder polyps are elevations of the gallbladder wall that
project into the lumen. They are commonly detected on ultra-
sound scans of the abdomen, with a prevalence estimated
between 0.3 and 9.5%. They may also be found following
analysis of the gallbladder specimen following cholecystecto-
my [1–5].
Gallbladder polyps can be divided into pseudopolyps and
true gallbladder polyps. Pseudopolyps are more common than
true polyps. In a recent systematic review by Elmasry et al.
70% of suspected gallbladder polyps were pseudopolyps [6].
Pseudopolyps are most commonly cholesterol pseudopolyps
but also include focal adenomyomatosis and inflammatory
pseudopolyps. Pseudopolyps do not in themselves have ma-
lignant potential. True gallbladder polyps can be benign or
malignant. Benign polyps are most commonly adenomas
while malignant polyps are usually adenocarcinomas. There
are rare types of benign and malignant true gallbladder polyps,
including mesenchymal tumours, lymphoma and metastases
[7]. Unlike the adenoma–carcinoma sequence that is well de-
scribed for colonic polyps, the adenoma–carcinoma sequence
in the gallbladder is less well understood. The evidence that
exists, however, suggests that at least some gallbladder ade-
nocarcinomas have arisen in pre-existing adenomas [8–10]
and as such the adenoma–carcinoma sequence is likely, at
least for some cases.
For the purposes of this review the term Bgallbladder
polyps^ will be used, although the authors acknowledge that
many apparent gallbladder polyps demonstrated on ultrasound
scans will in fact be pseudopolyps.
Gallbladder cancer, most commonly adenocarcinoma, is a
relatively rare form of cancer. The incidence varies significant-
ly between different ethnic groups. High risk groups, e.g.
Northern Indians and Native South Americans, see incidences
of up to 27/100,000while lower risk groups, such as Caucasian
North Americans, have an incidence of 1.5/100,000 [11].
Gallbladder cancer carries a poor prognosis once it becomes
advanced with 5-year survival less than 25% if tumour perfo-
rates the serosa (T3) or regional lymph nodes are involved
(N1) (stage III) [12]. If the cancer is confined to the muscularis
mucosa (stage I) or perimuscular connective tissue (stage II)
the 5-year survival rates are much more favourable at 100%
and 57–72%, respectively. It is important, therefore, that gall-
bladder cancer is detected and managed early. As gallbladder
polyps are common but gallbladder cancer is rare, it is a diag-
nostic challenge to determine which polyps are likely to be
malignant or undergo malignant transformation in order to
determine which patients require cholecystectomy.
Several groups of authors have suggested follow-up guide-
lines for gallbladder polyps based on systematic review of the
available literature [6, 7, 13–17]. As a result of factors such as
lack of randomised controlled trials, mostly low quality evi-
dence and inhomogeneity of studies, these follow-up guide-
lines differ. It may be difficult, therefore, for the practising
radiologist, clinician or sonographer to know what to recom-
mend when they encounter a gallbladder polyp. This was also
suggested by the results from a survey of surgeons by
Marangoni et al. [18] who found that there is inhomogeneity
of surgical practice in the management of gallbladder polyps.
To address this the European Society of Gastrointestinal
and Abdominal Radiology (ESGAR) sought to develop
evidence-based consensus guidelines with the aim of answer-
ing several questions: which patients require cholecystectomy,
which patients require ultrasound follow-up and what the fre-
quency and duration of follow-up should be. A group
consisting of gastrointestinal radiologists was formed for this
purpose. As this is an issue that affects multiple medical dis-
ciplines—most commonly gastrointestinal surgeons and gas-
troenterologists—representatives from these disciplines were
also included in compiling these guidelines. These guidelines
are applicable to all patients in whom a gallbladder polyp is
found on a conventional ultrasound scan.
Methodology
In March 2015, ESGAR members were contacted via email
for expressions of interest in contributing to these guidelines.
The ESGAR Guidelines Committee appointed a chair (SAR)
to oversee the guideline development, and the chair selected
five of the respondents, on the basis of their experience in
authorship of relevant literature or previous guideline devel-
opment (RW, RT, SR, CD and ML). By consensus a second
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chair was then appointed to facilitate guideline development
(RW). Through United European Gastroenterology, represen-
tatives from the International Society of Digestive Surgery
(YV, SB and JP), the European Association for Endoscopic
Surgery and other interventional techniques (MS) and the
European Society of Gastrointestinal Endoscopy (MA) were
invited to join the panel.
During the development process the principles of the
AGREE II instrument were used wherever possible [19].
A literature search was performed to include potentially
relevant articles published between January 1995 and
October 2015. A summary of the search strategy can be found
in Appendix. Abstracts of these articles were then evaluated
and from these, a list of relevant articles compiled and sent to
the group. Any additional suitable articles that were published
between October 2015 and September 2016 found by the
group could also be used as evidence. The literature primarily
deals with gallbladder polyps demonstrated on conventional
transabdominal ultrasound but other imaging modalities were
also considered (recommendations and statements related to
these can be found in the sections below).
Consensus was sought via a series of Delphi question-
naires, which were initially devised by the two chairs and
approved by the group. The group were asked to score agree-
ment with statements using a seven-point Likert scale (1 =
strongly disagree, 7 = strongly agree) [20]. Agreement was
determined if 75% of the group scored within 2 points;
75% agreement with a score of 6 or 7 meant that the recom-
mendation was accepted; 75% agreement with scores of 1 or 2
meant the recommendation was rejected. Where consensus
was not reached, a further Delphi round was performed. In
total three Delphi roundswere required. The group were asked
to grade the level of evidence using the GRADE system [21].
A draft manuscript was sent to the group by the coordinat-
ing chairs. The results were also discussed by group members
at a panel meeting during the annual ESGARmeeting, Prague,
16 June 2016.
The final manuscript was reviewed by the ESGAR
Guidelines Committee for approval prior to submission for
publication.
Recommendations and statements
A summary of the recommendations is described in the
algorithm (Fig. 1). Each point in the algorithm will be
discussed separately below. Diagnosis and follow-up are
based on transabdominal ultrasound. In cases of multiple
polyps the largest polyp should be used in deciding man-
agement. Grades of evidence as per the GRADE system
Fig. 1 Management algorithm
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[21] and agreement level of the group (in per cent) are
included in brackets after each statement.
Polyp definition
On ultrasound a gallbladder polyp is seen as an elevation of
the gallbladder wall that protrudes into the lumen. It should
not be mobile or demonstrate posterior acoustic shadowing
(which would suggest it is more likely a calculus). It may be
sessile or pedunculated.
A clearly infiltrating or large mass should be treated as a
gallbladder cancer rather than a polyp.
If there is clear reverberation or Bcomet tail^ artefact pres-
ent posterior to the lesion (Fig. 2) this should be identified as a
pseudopolyp (focal adenomyomatosis or a cholesterol polyp
[22, 23]). The follow-up guidelines, therefore, do not need to
be followed for these patients. Of note, not all pseudopolyps
will demonstrate these findings.
Polypoid lesion of the gallbladder greater than or equal
to 10mm—cholecystectomy is recommended if the patient
is fit for and accepts surgery (moderate quality evidence,
89% agreement)
The evidence of 10 mm as a cut-off value for cholecystectomy
is of moderate quality at best. This is due to a combination of
lack of randomised controlled trial data, mainly retrospective
studies and, in most cases, an arbitrary cut-off of 10 mm. In
addition, because of the relatively low prevalence of gallblad-
der cancer, power calculation (an indication of the minimum
number of subjects that need to be enrolled in a study to have
sufficient statistical power to determine risk) are likely to pro-
duce very large numbers of patients, which has thus far not
been achieved in any of the available literature. Despite this
limited evidence level, it seems that there is reasonable con-
sensus on the suggested recommendation in the published
literature, based principally on the observation of a greater
incidence of gallbladder carcinoma in the larger polyps [1, 7,
13–17, 24–36]. Moreover, there is evidence that suggests
pseudopolyps tend to be smaller than true polyps. Thus, if
cholecystectomy is performed for a gallbladder polyp
10 mm or larger then it is not only more likely that the lesion
is malignant but if it is not malignant then it is more likely to
be an adenoma and thus have malignant potential.
Some authors, such as Bhatt et al., have suggested higher
threshold values for cholecystectomy [14]. The group con-
cluded, however, that more evidence is available for the 10-
mm threshold.
The group recognises that cholecystectomy may not be
appropriate in all patients, e.g. patients with multiple comor-
bidities. In these patients discussion at a multidisciplinary
team (MDT) meeting is suggested. Follow-up ultrasound
may be useful in specific circumstances (e.g. if the patient is
adamant that they do not want surgery unless the gallbladder
polyp increases in size) but inappropriate in others (e.g. if
patient comorbidity means that the patient would never be
suitable for active treatment).
Polypoid lesion of the gallbladder with patient’s symptoms
attributable to the gallbladder—cholecystectomy is
suggested if there is no alternative cause for the patient’s
symptoms and the patient is fit for and accepts surgery
(low quality evidence, 89% agreement)
It is unlikely that small gallbladder polyps themselves cause
patient’s symptoms. There is evidence, however, that gallblad-
der polyps may be indicative of underlying inflammation or
stone disease that may not have been detected on ultrasound
[30, 37].
The relationship between symptoms and risk of malignan-
cy is not established. Some authors, e.g. Kwon et al., suggest
that if a patient with a gallbladder polyp has symptoms they
are more likely to have a malignant polyp [29]. Park et al.,
however, found no relationship on multivariate analysis [1].
One small study by Jones-Monahan et al. demonstrated
that of 45 symptomatic patients with gallbladder polyps and
no calculi who underwent cholecystectomy, 93% experienced
relief of symptoms [38].
French et al. concluded that, because the sensitivity and
specificity of ultrasound for predicting histology in gallblad-
der polyps are low, patients with symptoms attributable to the
gallbladder should have cholecystectomy, rather than follow-
up ultrasound, when a polyp is present [39].
Fig. 2 Pseudopolyps. This selected image from a transabdominal
ultrasound scan demonstrates three separate pseudopolyps. Note the
reverberation or Bcomet-tail^ artefact posterior to the lesions (arrows)
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Overall the evidence level for most of the studies is low.
The group concluded, however, that cholecystectomy is rea-
sonable if there are no other explanations for the patient’s pain.
The group recognises that not all patients will be consid-
ered suitable for cholecystectomy for a variety of reasons.
This includes patient comorbidity, patient preference or symp-
toms that are not convincingly attributable to the gallbladder.
In these patients, the group recommends that patients be
followed up as per the algorithm outlined above (unless for
whatever reason the patient would never be suitable for active
treatment).
If cholecystectomy is not indicated because
of the above reasons, the patient’s risk factors
for gallbladder malignancy should be established
and these patients should follow a more intensive
management plan (see below). These risk factors are:
– Age >50
– History of primary sclerosing cholangitis (PSC)
– Indian ethnicity
– Sessile polyp (including focal gallbladder wall
thickening >4 mm)
(Low-moderate quality evidence, 78% agreement).
Age
As with most other cancers, the risk of a gallbladder polyp
being malignant increases with increasing patient age. The
quality of evidence that patients who are older require more
regular follow-up or cholecystectomy for smaller polyps is
low, mainly as a result of retrospective studies, inhomoge-
neous data reporting and, in most cases, arbitrarily selected
cut-off values for age. The age threshold is variable across
studies. Some studies use a threshold of 50 years [14, 15,
33, 40] whilst others suggest 57 [1], 60 [24, 29, 36] or 65 years
[41]. Currently there is insufficient data to determine what the
most appropriate threshold is, or indeed whether patients of
different ages should be treated differently. Nevertheless the
group felt that, given the fact that gallbladder cancer is definite-
ly more common in older patients, age should be established as
a risk factor in the guidelines. The group concluded to use 50 as
the threshold for this but recognises that this is based on
consensus rather than conclusive scientific evidence.
Primary sclerosing cholangitis (PSC)
The American Association for the Study of Liver Diseases and
the European Association for the Study of the Liver both
recommend cholecystectomy for patients with PSC and a gall-
bladder polyp, irrespective of size [42, 43]. This is due to an
increased risk of malignancy in gallbladder polyps in patients
with PSC. A study by Said et al. demonstrated that in 18
patients with gallbladder masses and PSC, malignancy was
present in 56% of polyps in cholecystectomy specimens
[44], although these masses ranged in size from 5 to 35 mm.
Similarly in another study by Buckles et al. 57% of 14 gall-
bladder masses were malignant and 33% of the benign adeno-
mas demonstrated dysplasia [45], but again these lesions
ranged in size from 6 to 30 mm.
Other studies, however, have demonstrated fewer malig-
nant gallbladder polyps in patients with PSC. A more recent
study of patients with PSC by Eaton et al. demonstrated that
only 14% of 14 gallbladder polyps were malignant [46].
The quality of evidence in this area is low because of low
sample sizes, mostly retrospective studies and lack of primary
outcome data. Despite this, however, the evidence that is
available suggests that in patients with PSC a gallbladder pol-
yp is more likely to be malignant.
There is, however, an increased risk of complications in
patients with PSC undergoing cholecystectomy, particularly
those with advanced cirrhosis [46].
For the above reasons, the group felt that there was insuf-
ficient data to support cholecystectomy in all patients with
PSC and a gallbladder polyp, because of the potential in-
creased morbidity. The group felt, therefore, that these patients
should undergo a more intensive follow-up and have a lower
threshold for cholecystectomy than non-PSC patients.
However, the group recognises that cholecystectomy may
not be appropriate in all patients because of patient comorbid-
ities. As such, if cholecystectomy cannot be performed safely
the follow-up schedule outlined in the algorithm could be
adopted.
Indian ethnicity
A large study by Aldouri et al. involving 2359 patients with
gallbladder polyps demonstrated that on multivariate analysis
patients of Indian ethnicity had a significantly higher preva-
lence of gallbladder cancer: 5.5% versus 0.08% [24]. Whilst
this is the only paper, to our knowledge, that has specifically
studied this risk factor, given that it is a relatively large cohort
and of a moderate level of evidence, the group felt that it was
reasonable to include this in the guidelines. More studies,
preferably prospective, would be required to confirm the
recommendations.
Sessile polyp (including focal GB wall thickening >4 mm)
A recently published systematic review by Bhatt et al. dem-
onstrated that sessile morphology in a gallbladder polyp is an
independent risk factor for malignancy, increasing the risk by
a factor of 7.32 (95% confidence interval 4.18–12.82) [14].
This was similar to a finding in a retrospective study by Kwon
et al. of 291 patients with a gallbladder polyp on
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cholecystectomy that demonstrated an odds ratio of 7.70 (95%
confidence interval 2.48–23.95) [29].
A larger retrospective study by Park et al. of 689 patients
with gallbladder polyps [1] demonstrated that sessile morphol-
ogy was a risk factor on univariate but not multivariate analy-
sis. It should be noted that the majority of patients in this study
were followed upwith ultrasound rather than cholecystectomy.
Overall the group felt that sessile morphology should be
included as a significant risk factor for malignancy in the
guidelines.
It has been suggested by some authors that gallbladder wall
thickening is an indication of malignancy. Two studies have
demonstrated increased risk of malignancy in patients with
wall thickening. Aldouri et al. [24] demonstrated that wall
thickening >5 mm and wall irregularity were both indepen-
dent risk factors for malignancy on multivariate analysis (al-
though these were secondary outcomes in the study). This
subgroup of patients, however, did not have gallbladder
polyps.
Another study by Zhu et al. [47] of 29 elderly patients in
whom gallbladder cancer was found incidentally on cholecys-
tectomy showed that wall thickening >4 mm was an indepen-
dent variable for gallbladder cancer (P = 0.002). This study,
however, did not deal only with patients who had cancer in
polyps. It is also limited by its small sample size and patient
demographics.
A further study of 361 patients by Choi et al. [27] demon-
strated that patients with gallbladder wall thickening (defined
as 3 mm or more) were more likely to undergo subsequent
cholecystectomy for whatever reason, compared to patients
without thickening. In this study, however, no patients subse-
quently developed malignancy and as such the relevance of
this study in determining that wall thickening is associated
with malignancy is doubtful. It may indicate, however, that
patients with wall thickening are more likely to develop symp-
toms leading to cholecystectomy, but this is speculative.
Again there are no prospective studies or randomised con-
trolled trials. As such the level of evidence is low and further
studies are needed.
The group feels that patients with focal wall thickening
>4 mm should be treated the same as patients with sessile
polyps.
Other risk factors
The group recognises that other factors probably make
gallbladder malignancy more likely. Some studies suggest
that solitary gallbladder polyps, for example, are more
likely to be malignant than multiple polyps [6, 14],
although the increased risk of malignancy in the systematic
review by Bhatt et al. was only 2.05. Other studies, how-
ever, have shown this not to be significant on multivariate
analysis [24]. There are no robust data, to our knowledge, that
suggest asymptomatic multiple polyps are less likely to be
malignant than asymptomatic solitary polyps. The group
concluded that a solitary polyp should not be included as a
specific risk factor.
People of Indian ethnicity, as described above, appear to
have increased risk of malignancy in gallbladder polyps [24].
Other ethnic groups, for example East Asians, also appear to be
at high risk of gallbladder cancer [13]. To the best of our knowl-
edge, however, there are no studies that have directly compared
the prevalence of malignancy in gallbladder polyps in ethnic
groups other than Indian. As such, whilst it may be that polyps
in other ethnic groups are more likely to be malignant, this has
not been fully established and as such was not included in the
guidelines. This is again an area for future research.
Some authors have suggested that the presence of gall-
stones may be a risk factor for malignancy in gallbladder
polyps. Aldouri et al. [24], for example, demonstrated that
the presence of gallstones was an independent risk factor but
with borderline significance. Park et al., however, found that
gallstones were not an independent risk factor on multivariate
analysis [1]. Again the evidence level in this area is low. The
group concluded that there was insufficient evidence to in-
clude gallstones as a strong risk factor in the guidelines, but
note that some of these patients are likely to be symptomatic
and as such will undergo cholecystectomy anyway.
If the patient has risk factors for gallbladder malignancy
and a polyp 6–9 mm, cholecystectomy is recommended if
the patient is fit for and accepts surgery (low–moderate
quality evidence, 78% agreement)
For the reasons stated above, patients with the above risk
factors have a higher risk of gallbladder malignancy. As such
the threshold of 10 mm as an indication for cholecystectomy
should be lowered in these patients to 6 mm.
As for polyps 10 mm or greater, if the patient is not fit for
surgery, either because of comorbidities or patient choice, the
decision to perform follow-up will be based on the individual
case in question. This may require MDT discussion. If a
follow-up approach is decided upon, follow-up as per patients
with no risk factors is advised.
If the patient has either
No risk factors for gallbladder malignancy and a gallblad-
der polyp of 6–9 mm or
Risk factors for malignancy and a gallbladder polyp 5mm
or less
Follow-up ultrasound of the gallbladder is recommended
at 6 months, 1 year and then yearly up to 5 years.
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If the patient has no risk factors for malignancy and a
gallbladder polyp of 5 mm or less follow-up is advised at
1 year, 3 years and 5 years
(Low quality evidence, 78% agreement).
Small gallbladder polyps are less likely to be malignant, or
have malignant potential than larger polyps [48]. In a small
number of cases, however, malignancy has been found in
polyps <6 mm [24, 35]. Perhaps more importantly adenomas
havemore commonly been found in polyps <6mm. Roa et al.,
for example, found that of 32 adenomas found following cho-
lecystectomy 47% were <5 mm [49]. Another study by
Kubota et al. [50] demonstrated that two out of the seven
gallbladder polyps <5 mm found following cholecystectomy
were adenomas.
Given the potential risk of malignancy, the group felt that
an early follow-up ultrasound scan (at 6 months) followed by
a scan at 12 months was warranted for patients with gallblad-
der polyps <6 mm and risk factors or for patients with larger
polyps 6–9 mm and no risk factors. If a small gallbladder
polyp were malignant at the time of the first scan then it is
more likely to demonstrate growth by 6 months. The group
did not feel this 6-month initial scan was required in patients
with very low risk (i.e. no risk factors and polyp <6 mm).
The rest of the follow-up schedule suggested is at yearly
intervals. This is to attempt to detect any small adenomas that
undergo malignant change.
As described earlier, the adenoma–carcinoma sequence for
gallbladder polyps seems likely, but there is insufficient data
to suggest how long an adenoma is likely to be present before
undergoing malignant change. In one study by Park et al. a
polyp took 7 years to grow [32]. Wiles et al. demonstrated in a
systematic review that gallbladder polyps that do grow appear
to do so slowly [51]. The group concluded that a 5-year fol-
low-up should be advised.
The group recognises that, again, there is a lack of robust
data on which these recommendations have been made and
that large prospective studies are needed to establish good
evidence.
If during follow-up gallbladder polyp increases by 2 mm
or more cholecystectomy advised (moderate quality
evidence 78% agreement)
Few gallbladder polyps grow on follow-up. A recent system-
atic review by Bhatt et al. [14] found that 93% of polyps did
not increase in size. Growth rate, however, appears to be a
potential risk factor for malignancy. Cairns et al. [25] demon-
strated that in 467 patients with gallbladder polyps who
underwent ultrasound follow-up, progression in size was pre-
dictive of malignancy or malignant potential. This study was
limited, however, by a low prevalence of malignant or
potentially malignant lesions (3.7%). In addition the progres-
sion in size was not defined.
Park et al. demonstrated that in 1558 patients with gallblad-
der polyps, 33 of which proved to be neoplastic, 25% of gall-
bladder polyps that increased in size were neoplastic [32].
A systematic review [51] by Wiles et al. that looked at
growth of gallbladder polyps concluded that there were insuf-
ficient data to conclude what rate of growth in a gallbladder
polyp is suggestive of malignancy. This was mainly due to
growth rate not being reported inmost studies, as well as small
numbers of neoplastic polyps. In one study by Shin et al.
growth rate of >0.6 mm/month was associated with malignan-
cy on univariate but not multivariate analysis [34], although
only 20 patients out of 145 had a neoplastic polyp.
In summary, it appears that increase in size may be a pre-
dictor for neoplasia, but no specific size increase has been
established. The group felt that a 1-mm increase was too small
because of differences in scanning techniques and ultrasound
resolution but that 2 mm would more likely be representative
of true growth. This is supported by evidence from a study by
Sugiyama et al. [23] who demonstrated that in 58 patients who
underwent conventional ultrasound and cholecystectomy for
gallbladder polyps, the size of the polyp on ultrasound was
within 2 mm of the size on cholecystectomy and was also
within 2 mm of the size measured on EUS. Thus a size in-
crease of 2 mm on ultrasound is likely to represent a true size
increase, rather than being a spurious finding.
If during follow-up gallbladder polyp reaches 10 mm
cholecystectomy advised (moderate quality evidence,
100% agreement)
Gallbladder polyps 10 mm or greater are more likely malig-
nant, as described above and as such cholecystectomy is
advised.
If during follow-up gallbladder polyp disappears
discontinue follow-up (moderate quality evidence, 100%
agreement)
If the gallbladder polyp disappears then it was likely a
pseudopolyp and does not require further follow-up. This is
assuming that there were no limitations to the quality of the
scan (such as a non-distended gallbladder).
In some cases, decision regarding cholecystectomy may be
reached following multidisciplinary discussion
In some cases a patient may meet the criteria for cholecystec-
tomy but the surgeon to whom the patient has been referred
may not consider this the appropriate course of action. This
may include patients with significant comorbidities, advanced
age or due to patient choice. In these cases multidisciplinary
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discussion, including between the surgeon and radiologist, is
advised.
Primary investigation should be with abdominal
ultrasound. Routine use of other imaging modalities is not
recommended. In some centres with appropriate expertise
and resources, alternative imaging modalities (such
as endoscopic ultrasound) may be useful to aid
decision-making in difficult cases (low quality evidence,
100% agreement)
Alternative imaging modalities have shown promising results
in some studies on small numbers of patients.
EUS has been shown to be more accurate than convention-
al ultrasound in some small studies. In a study by Sugiyama
et al. [23] of 58 patients with suspected gallbladder polyp who
underwent cholecystectomy, EUS correctly distinguished be-
tween true and pseudopolyps in 97%. The figure for conven-
tional ultrasound was 76% (which was statistically signifi-
cant). In another study by Cheon et al. [52] of 94 patients with
gallbladder polyps less than 20 mm who underwent cholecys-
tectomy the diagnostic accuracy of EUS and conventional
ultrasound was 80.9% and 63.9%, respectively (which was
statistically significant), although for gallbladder polyps less
than 11 mm these figures were 79.7% and 72.4% which may
be more relevant to these guidelines.
Contrast enhanced ultrasound (CEUS) has been used to
assess gallbladder polyps in some studies. In a multicentre
study by Zheng et al. [53] of 116 patients with gallbladder
polyps who underwent cholecystectomy it was demonstrated
that CEUS increased diagnostic accuracy for characterisation
of the lesions for gallbladder polyps >10 mm but not <10 mm.
In a study by Liu et al. [54] of 83 patients with gallbladder
polyps who underwent cholecystectomy and CEUS, whilst
some of the imaging characteristics appeared to correlate with
the histological diagnosis, these were not statistically
significant.
Jang et al. [55] studied 144 patients who underwent chole-
cystectomy and high resolution ultrasound (HRUS). The high
resolution technique involved using a high frequency probe
and selective use of harmonic imaging. They found that for
HRUS and EUS the sensitivity and specificity for diagnosing
malignancy were similar (sensitivity 89.6% and 86.2%, spec-
ificity 86.9% and 86.9%, respectively). This study, however,
did not compare HRUS with conventional ultrasound and did
not assess accuracy at differentiating adenomas from
pseudopolyps. Perhaps most importantly, the authors only
studied gallbladder polyps >10 mm, which introduces poten-
tial bias and means the findings of the study cannot be applied
to the management of patients with small polyps.
Some authors have studied the use of computed tomogra-
phy (CT) in diagnosing gallbladder polyps. Furukawa et al.
[56] demonstrated that all gallbladder polyps that were
histologically confirmed following cholecystectomy were de-
tected by contrast enhanced CT. The study was limited by a
small sample size, however, with only five gallbladder polyps
less than 11 mm in size. In a study by Lou et al. of 32 patients
[57], CT biliary cystography was evaluated and the detection
rates for gallbladder polyps were comparable with conven-
tional ultrasound (detection rates of 93.8% (90/96) and
96.9%, respectively). This study mainly involved polyps less
than 10mm (86% of polyps). Although this is promising early
data, the numbers were again small.
Magnetic resonance imaging (specifically diffusion
weighted imaging, DWI) was studied by Irie et al. [58] who
demonstrated that ADC values of benign gallbladder polyps
were higher than malignant lesions. This evaluated only 23
patients and all polyps were 10 mm or larger. As such the
results cannot be applied generally.
In summary, alternative imaging modalities, particularly
EUS, may provide additional information in the diagnosis of
gallbladder polyps. At present, however, there is insufficient
data to suggest that they should be used ahead of conventional
ultrasound in the investigation of gallbladder polyps. In addi-
tion transabdominal ultrasound is a relatively low cost, low
risk and widely available technique which means that
transabdominal ultrasound-based guidelines can be followed
by most, if not all, European centres, rather than in specific
specialist centres. Some centres with sufficient resources and
expertise may find the additional information available useful,




The level of evidence in most of the studies on which these
guidelines are based is low or moderate at best as mentioned
throughout this report. Most of the studies are retrospective
and from single centres and many are biased, most commonly
by the fact that patients who underwent cholecystectomy had
large polyps or symptoms. In addition the rarity of gallbladder
cancer means that studies with large sample sizes would be
required to truly determine which gallbladder polyps are likely
to undergo malignant change. The majority of studies only
achieved small numbers. This makes formulating guidelines
for the management of small polyps particularly difficult,
which is reflected in the inhomogeneity of recommendations
from the authors of systematic reviews [6, 7, 13–17]. This also
explains why only two of the recommendations described
above are based on moderate quality evidence and had
100% agreement between the authors—BIf during follow-up
gallbladder polyp reaches 10 mm cholecystectomy advised^
Eur Radiol
and BIf during follow-up gallbladder polyp disappears dis-
continue follow-up^.
A large, longitudinal multicentre trial is required to reliably
answer the question of which patients require cholecystecto-
my, which patients require ultrasound follow-up and what the
frequency and duration of that follow-up should be. The group
wishes to stress that the development and publication of these
guidelines should not preclude further research into this area.
Cost of implementing the guidelines
The group proposes infrequent but long follow-up for gall-
bladder polyps. Estimating the cost of implementing these
guidelines is difficult. Cairns et al. [25] studied 986 patients
with gallbladder polyps and looked at the cost-effectiveness of
ultrasound surveillance. They estimated that the surveillance
programme would prevent 5.4 gallbladder cancers per 1000
patients scanned annually. On the basis of a number of pricing
assumptions and 6-monthly ultrasound surveillance, they es-
timated that ultrasound surveillance was cost-effective when
the cost of 5.4 gallbladder cancers per 1000 patients was taken
into account. The authors made a number of assumptions in
the study, including that all neoplastic polyps would become
malignant. Whilst this data is not robust, it can be suggested
that a surveillance programme may be cost-effective.
Scanning at 12-monthly intervals may further increase this
saving.
Adherence to guidelines
The group aimed to make the guidelines applicable to hospi-
tals throughout Europe. This included the suggestion of a
purely conventional ultrasound-based follow-up programme.
The guidelines have been formulated into an algorithm that, it
is hoped, will be unambiguous and easy to follow.
Patient involvement
To our knowledge there is no specific European patient focus
group. The acceptance of these guidelines by patients is likely
to vary across Europe. It was, therefore, not possible to in-
clude patient groups in the formulation of these guidelines as
recommended in AGREE II. Conventional transabdominal
ultrasound is, however, non-invasive, radiation- and
contrast-free and relatively quick and simple to perform. We
anticipate, therefore, that there should not be any specific bar-
riers to patient acceptance of these guidelines, providing that
the referring clinician describes to the patient the rationale for
the scan and entry into a follow-up algorithm. This may also
provide an opportunity for further research.
Updating the guidelines
The group suggests that the guidelines are updated in
September 2021 or earlier if robust new evidence becomes
available that would significantly modify the recommenda-
tions.
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Table 1 The literature search strategy is outlined below. MEDLINE
and EMBASE databases were searched using search terms Bgallbladder^
and Bpolyp^, excluding case studies and limited to English language
papers. Abstracts of all articles published between January 1995 and
October 2015 were then reviewed.
1 Medline (Bgall bladder*^ OR gallbladder*).ti 17699
2 Medline polyp*.ti 60841
3 Medline 1 AND 2 363
4 Medline 3 NOT Bcase report*^ 346
5 Medline 4 [Limit to: (Language English)] 250
6 EMBASE 4 [Limit to: (Language English)] 248
7 Medline,
EMBASE
Duplicate filtered: [4 [Limit to:
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